Pharmaceutical giant Pfizer close to reach $9b deal with Nestle

Pharmaceutical giant Pfizer close to reach $9b deal with Nestle

PanARMENIAN.Net - U.S. pharmaceutical giant Pfizer is close to reaching a $9 billion deal to sell its infant nutrition business to Nestle, AFP reports citing the Wall Street Journal.

The Journal said Nestle, the Swiss food giant, had apparently beaten out Groupe Danone and Mead Johnson Nutrition, which had considered a joint bid for the business, and that the final deal could be announced next week.

A Pfizer spokeswoman contacted by AFP refused to comment on the report, saying "no decisions have been made at this point" on the sale of the infant nutrition business or an animal health business also set to be auctioned off.

"The animal health and nutrition businesses are highly valued assets, and our decision about strategic options will be driven by value creation and delivering the best after-tax value for our shareholders," she said.

Pfizer has moved to unload peripheral entities in recent months in order to focus on its core medicine business.

In November its patent on the best-selling drug of all time, the cholesterol-lowering medication Lipitor, expired, opening the path to generic competitors for America's most popular medication.

 Top stories
Iran’s Alireza Kameli said that an average of one million cubic meters of natural gas is currently being exported to Armenia.
According to Minister Yervand Zakharyan, about $220 million will be invested in the project; the agreement will be signed within four months.
Maufacturing of tobacco products increased by 49.1% to AMD 94 bn, with production of jewelry also climbing 61% to AMD 18 bn.
Net inflow of remittances to Armenia in the reporting period amounted to approximately $891,4 million, down by 35.8% remitted in 2014.
Partner news